European Patent Office

T 0916/16 (Compositions of glycopyrronium salt for inhalation / NOVARTIS) of 15.12.2020

European Case Law Identifier
ECLI:EP:BA:2020:T091616.20201215
Date of decision
15 December 2020
Case number
T 0916/16
Online on
28 January 2021
Petition for review of
-
Application number
07764925.9
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION
Applicant name
Novartis AG
Opponent name
Teva UK Limited
Board
3.3.07
Headnote
-
Relevant legal provisions
European Patent Convention Art 100(a) (2007)European Patent Convention Art 56 (2007)Rules of procedure of the Boards of Appeal Art 13(1) (2020)
Keywords
Inventive step - (no)
Late-filed document - admitted (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.